FDA Clears Fully Automated West Nile Virus Platform
This article was originally published in The Gray Sheet
Executive Summary
Novartis can now sell its Procleix Tigris automated testing platform at commercial pricing levels to facilities screening blood for West Nile Virus following FDA clearance March 2